Carriers for the targeted delivery of aerosolized macromolecules for pulmonary pathologies

被引:69
|
作者
Osman, Nashwa [1 ]
Kaneko, Kan [1 ]
Carini, Valeria [1 ]
Saleem, Imran [1 ]
机构
[1] Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Byrom St, Liverpool L3 3AF, Merseyside, England
基金
英国医学研究理事会;
关键词
Aerosol devices; inhaled macromolecules; lung delivery; microcarrier; nanocarrier; nanomedicine; lipid-based systems; passive and active targeting; pulmonary pathologies; DRY POWDER INHALATION; DRUG-DELIVERY; GENE DELIVERY; PROTEIN; NANOPARTICLES; LIPOSOMES; NANOCARRIERS; SURFACTANT; CHALLENGES; PEPTIDE;
D O I
10.1080/17425247.2018.1502267
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Macromolecules with unique effects and potency are increasingly being considered for application in lung pathologies. Numerous delivery strategies for these macromolecules through the lung have been investigated to improve the targeting and overall efficacy.Areas covered: Targeting approaches from delivery devices, formulation strategies and specific targets are discussed.Expert opinion: Although macromolecules are a heterogeneous group of molecules, a number of strategies have been investigated at the macro, micro, and nanoscopic scale for the delivery of macromolecules to specific sites and cells of lung tissues. Targeted approaches are already in use at the macroscopic scale through inhalation devices and formulations, but targeting strategies at the micro and nanoscopic scale are still in the laboratory stage. The combination of controlling lung deposition and targeting after deposition, through a combination of targeting strategies could be the future direction for the treatment of lung pathologies through the pulmonary route.
引用
收藏
页码:821 / 834
页数:14
相关论文
共 50 条
  • [41] Lipid-based colloidal carriers for targeted siRNA delivery
    Colombo, Stefano
    Foged, Camilla
    THERAPEUTIC DELIVERY, 2012, 3 (11) : 1245 - 1247
  • [42] Glucan Particles as Carriers of Nanoparticles for Macrophage-Targeted Delivery
    Soto, Ernesto
    Ostroff, Gary
    NANOMATERIALS FOR BIOMEDICINE, 2012, 1119 : 57 - 79
  • [43] Human Insulin Microcrystals with Lactose Carriers for Pulmonary Delivery
    Lim, Se-Hwan
    Park, Hye Won
    Shin, Chang-Hoon
    Kwon, Jai-Hyun
    Kim, Chan-Wha
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2009, 73 (12) : 2576 - 2582
  • [44] Unraveling the pulmonary drug delivery carriers in inhalable nanostructures
    Zhengwei Huang
    Linjing Wu
    Wenhao Wang
    Yue Zhou
    Xuejuan Zhang
    Ying Huang
    Xin Pan
    Chuanbin Wu
    Journal of Nanoparticle Research, 2022, 24
  • [45] Nasal and pulmonary vaccine delivery using particulate carriers
    Jia, Yimei
    Krishnan, Lakshmi
    Omri, Abdelwahab
    EXPERT OPINION ON DRUG DELIVERY, 2015, 12 (06) : 993 - 1008
  • [46] Swellable Microparticles as Carriers for Sustained Pulmonary Drug Delivery
    El-Sherbiny, Ibrahim M.
    McGill, Shayna
    Smyth, Hugh D. C.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 99 (05) : 2343 - 2356
  • [47] Targeted Delivery of Therapeutic Oligonucleotides to Pulmonary Circulation
    Wilson, Annette
    He, Fengtian
    Li, Jiang
    Ma, Zheng
    Pitt, Bruce
    Li, Song
    NON-VIRAL VECTORS FOR GENE THERAPY, SECOND EDITION: PART 2, 2005, 54 : 21 - 41
  • [48] Advancements in nanotechnology for targeted drug delivery in idiopathic pulmonary fibrosis: a focus on solid lipid nanoparticles and nanostructured lipid carriers
    Prakaash, K. K. Suriya
    Narayansamy, Damodharan
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2025,
  • [49] Macromolecules-based encapsulation of pesticides with carriers: A promising approach for safe and effective delivery
    Riseh, Roohallah Saberi
    Vatankhah, Masoumeh
    Hassanisaadi, Mohadeseh
    Kennedy, John F.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 269
  • [50] Recent Advances in Non-Invasive Delivery of Macromolecules using Nanoparticulate Carriers System
    Shadab, Md
    Haque, Shadabul
    Sheshala, Ravi
    Meng, Lim Wei
    Meka, Venkata Srikanth
    Ali, Javed
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (03) : 440 - 453